Calypso Biotech
Calypso Biotech
Dutch Biotech Firm Raises €75m to Fight Diseases
BIOT
💰 Dutch biotech firm Forbion leads €75m funding for Calluna Pharma, a newly formed company targeting inflammatory and fibrotic diseases.
Major Leadership Changes in Oncology Biotechs: What’s Next?
BIOT
📰 Ins & Outs: C-suite changes across oncology biotechs explores recent leadership transitions in cancer-focused biotech companies. 👥🌟🏥🧪🔬
Novartis Acquires Immunology Specialist in $425M Deal
BIOT
📰 Novartis AG to buy immunology specialist Calypso Biotech BV for $425 million. 💉 Acquisition includes potential autoimmune treatment CALY-002. 🧪 Exciting developments in celiac disease and eosinophilic esophagitis research.
